AVHHL   $3.12  -9.57% Market Closed

AVITA MED INC CDI

Current temperature:
ST: None, Cor:

Analyst Recommendations:
Number of estimates 4
Target Price Mean 2
Mean unverified/preliminary 2 / 2
Target Price Low / High 1 / 3
Median / STD DEV 2 / 0.87
ISIN AU000000AVH4
ceo Mr. James M. Corbett
Website https://www.avitamedical.com
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.